Humacyte (HUMA) Other Non Operating Income (2021 - 2026)

Humacyte (HUMA) has 6 years of Other Non Operating Income data on file, last reported at $8.5 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $8.5 million, down 42.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.4 million (up 117.62% YoY), and the FY2025 annual result was $38.8 million, changed N/A from the prior year.
• Other Non Operating Income slipped to $8.5 million in Q1 2026 per HUMA's latest filing, from $20.6 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $20.6 million in Q4 2025 and troughed at -$2.4 million in Q2 2023.
• A 5-year average of $3.2 million and a median of $40500.0 in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 3523.81% in 2024, then jumped 24783.33% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $417000.0 in 2022, then slumped by 94.96% to $21000.0 in 2023, then tumbled by 3523.81% to -$719000.0 in 2024, then surged by 2961.47% to $20.6 million in 2025, then plunged by 58.56% to $8.5 million in 2026.
• Business Quant data shows HUMA's Other Non Operating Income at $8.5 million in Q1 2026, $20.6 million in Q4 2025, and $4.0 million in Q3 2025.